TY  - JOUR
AU  - Marín-Jiménez, Juan A
AU  - Oliva, Marc
AU  - Peinado Martín, Paloma
AU  - Cabezas-Camarero,  Santiago
AU  - Plana Serrahima, Maria
AU  - Vázquez Masedo, Manuel Gonzalo
AU  - Lozano Borbalas, Alicia
AU  - Cabrera Martín, María Nieves
AU  - Esteve, Anna
AU  - Iglesias Moreno, María Cruz
AU  - Vilajosana Altamis, Esther
AU  - Arribas Hortigüela, Lorena
AU  - Taberna Sanz, Miren
AU  - Pérez Segura, Pedro
AU  - Mesía, Ricard
PY  - 2022
DO  - 10.3389/fonc.2022.953020
UR  - https://hdl.handle.net/20.500.14352/115270
T2  - Frontiers in oncology
AB  - Objectives: Induction chemotherapy (ICT) followed by definitive treatment is an accepted non-surgical approach for locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC). However, ICT remains a challenge for cisplatin-unfit patients....
LA  - eng
M2  - 953020
PB  - Frontiers Research Foundation
KW  - Head and neck squamous cell carcinoma
KW  - Cetuximab
KW  - Cisplatin
KW  - Head and neck cancer
KW  - Induction chemotherapy
KW  - Paclitaxel
KW  - Radiotherapy
KW  - Unfit patient
TI  - Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
TY  - journal article
VL  - 12
ER  -